Previous Article | Next Article 
Journal of Virology, July 2001, p. 5930-5938, Vol. 75, No. 13
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.13.5930-5938.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Theiler's Murine Encephalomyelitis Virus Induces
Apoptosis in Gamma Interferon-Activated M1 Differentiated
Myelomonocytic Cells through a Mechanism Involving Tumor Necrosis
Factor Alpha (TNF-
) and TNF-
-Related Apoptosis-Inducing
Ligand
Mary Lou
Jelachich* and
Howard L.
Lipton
Evanston Northwestern Healthcare Research
Institute and Northwestern University, Evanston, Illinois 60201
Received 20 November 2000/Accepted 3 April 2001
 |
ABSTRACT |
Infection of susceptible mice with the low-neurovirulence
Theiler's murine encephalomyelitis virus strain BeAn results in an
inflammatory demyelinating disease similar to multiple sclerosis. While
the majority of virus antigen is detected in central nervous system
macrophages (M
s), few infiltrating M
s are infected. We used the
myelomonocytic precursor M1 cell line to study BeAn virus-M
interactions in vitro to elucidate mechanisms for restricted virus expression. We have shown that restricted BeAn infection of M1 cells
differentiated in vitro (M1-D) results in apoptosis. In this study,
BeAn infection of gamma interferon (IFN-
)-activated M1-D cells also
resulted in apoptosis but with no evidence of virus replication or
protein expression. RNase protection assays of M1-D cellular RNA
revealed up-regulation of Fas and the p55 chain of the tumor necrosis
factor alpha (TNF-
) receptor transcripts with IFN-
activation.
BeAn infection of activated cells resulted in increased caspase 8 mRNA
transcripts and the appearance of TNF-
-related apoptosis-inducing
ligand (TRAIL) 4 h postinfection. Both unactivated and activated
M1-D cells expressed TRAIL receptors (R1 and R2), but only activated
cells were killed by soluble TRAIL. Activated cells were also
susceptible to soluble FasL- and TNF-
-induced apoptosis. The data
suggest that IFN-
-activated M1-D cell death receptors become
susceptible to their ligands and that the cells respond to BeAn virus
infection by producing the ligands TNF-
and TRAIL to kill the
susceptible cells. Unactivated cells are not susceptible to FasL or
TRAIL and require virus replication to initiate apoptosis. Therefore,
two mechanisms of apoptosis induction can be triggered by BeAn
infection: an intrinsic pathway requiring virus replication and an
extrinsic pathway signaling through the death receptors.
 |
INTRODUCTION |
Theiler's murine
encephalomyelitis virus (TMEV) is a member of the family
Picornaviridae, genus Cardiovirus, and a natural enteric pathogen of mice. TMEV has been divided into two groups based
on neurovirulence following intracerebral inoculation of genetically
susceptible mice. Infection with BeAn, a low-neurovirulence strain,
results in a chronic, demyelinating disease of the central nervous
system (CNS). Persistence of BeAn virus leads to activation of major
histocompatibility complex class II-restricted CD4+ Th1
lymphocytes directed at virus epitopes (11, 13, 14, 33,
34) and immunopathologic damage of myelin. This animal model has
been used as an experimental analogue of multiple sclerosis.
During TMEV persistence, the major virus antigen burden resides in CNS
macrophages (M
s) (12, 29, 37); however, only a
relatively small percentage of M
s infiltrating demyelinating lesions
contain detectable virus antigen (29), and an infected M
produces only 1 to 5 PFU (12). To investigate
virus-M
interactions that might lead to restricted virus
replication, we have used the myelomonocytic precursor cell line, M1.
Recently, it was reported that the M1 cell line was susceptible to
virus infection only after differentiation into M
-like cells (M1-D
cells) (22). BeAn infection of M1-D cells is highly
restricted and results in apoptotic cell death that requires virus
replication. In the present study, M1-D cells were treated with gamma
interferon (IFN-
) prior to BeAn virus infection to determine whether
activated M
s secreting antiviral cytokines would inhibit BeAn virus
replication and to explain, at least in part, the low virus titers in
the spinal cords of infected mice. As expected, BeAn-infected,
IFN-
-activated M1-D cells showed no evidence of virus replication;
unforeseen was the observation that activated M1-D cells died by apoptosis.
We describe experiments to define the mechanism(s) by which activated
M1-D cells die after BeAn infection. Soluble FasL, tumor necrosis
factor alpha (TNF-
), and TNF-
apoptosis-inducing ligand (TRAIL)
induced significant cell death in M1-D cells after IFN-
activation.
RNase protection assay (RPA) showed increased Fas and TNF-R p55 (p55
chain of the TNF-
receptor) mRNA transcript levels with activation
alone and increased TRAIL mRNA with activation and infection.
One possible scenario suggested by the data is that IFN-
activation
sensitizes these cells to death-inducing ligands. Virus infection after
activation also causes increased IFN-
/
(22) and
results in up-regulation of TRAIL and increased secretion of TNF-
,
both of which result in cell death. Thus, depending on the activation
state, BeAn virus induces apoptosis in M
s either through an
intrinsic mechanism requiring virus replication or through an extrinsic
mechanism involving the death receptors and their ligands.
 |
MATERIALS AND METHODS |
Cells, viruses, and reagents.
M1-D cells were differentiated
from the M1 cell line with supernatants from L929 and P388D1 cells as
previously described (22) and maintained in complete
medium containing 10% fetal bovine serum. Cells were either left
untreated or treated with 100 U of IFN-
(Sigma, St. Louis, Mo.) per
ml for 24 h unless otherwise specified. Soluble TRAIL was a
generous gift of James Pan (Genentech, South San Francisco, Calif.),
TNF-
was purchased from Sigma, and soluble FasL was purchased from
Alexis Corporation (San Diego, Calif.). TNF-
was analyzed by the
mouse TNF-
immunoassay kit, Quantikine M, from R&D Systems
(Minneapolis, Minn.). The inhibitors soluble TNF-
RII (sTNF-RII) and
recombinant human TRAIL-R2:Fc (rhTRAIL-R2:Fc) were obtained from
Oncogene Research Products (Cambridge, Mass.) and from Alexis
Corporation, respectively. The origin and passage history of the BeAn
virus stock have been described (39). Virus titers of
clarified lysates of infected cells were determined by standard plaque
assay on BHK-21 cells (39).
Virus infections.
After virus adsorption at a multiplicity
of infection of 10, or as indicated, for 45 min at 24°C, M1-D cells
were washed with phosphate-buffered saline, pH 7.2, and incubated in
complete RPMI medium containing 5% fetal bovine serum at 37°C in a
5% CO2 atmosphere for the indicated times.
MTT assay.
Cell viability was determined by the conversion
of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
to blue formazan crystals as previously described (23).
Briefly, 104 cells were incubated for 2 to 4 h with 50 µl of MTT (1 mg/ml) 20 to 24 h after infection and/or treatment
with cytokines. Formazan crystals were dissolved in 100 µl of
dimethyl sulfoxide, and the optical density at 560 nm
(OD560) was read on a UV Max microplate reader (Molecular
Diagnostics, Palo Alto, Calif.). Statistical analysis was performed on
quadruplicate samples using Cricket Graph 1.3 unless otherwise indicated.
Flow cytometry.
After blocking nonspecific antibody binding
with 10% goat serum and/or 2 µl of anti-CD32/16 (FcR) (PharMingen,
San Diego, Calif.), cells were incubated with polyclonal rabbit
anti-BeAn antiserum (1:1,000), polyclonal rabbit anti-TRAIL antiserum
(1:100)(Alexis Corporation), or hamster anti-FasL monoclonal antibody
(1:100) (PharMingen). Secondary antibodies were fluorescein
isothiocyanate (FITC)-conjugated goat anti-rabbit immunoglobulin G
(IgG) F(ab')2 (1:200) (Cappel/Organon Teknikon, Durham,
N.C.) and biotinylated anti-hamster IgG cocktail (1:100) (PharMingen).
A 1:200 dilution of avidin-FITC (PharMingen) was used as the
fluorochrome for the biotinylated antibody. Cytoplasmic antigen was
detected as previously described (21). After staining,
cells were fixed in 1% paraformaldehyde and analyzed on a FACSCalibur
(Becton Dickinson, Palo Alto, Calif.). Data were evaluated using
CELLQuest 3.1f supplied with the instrument. Annexin V staining using
Annexin V-FITC apoptosis detection kit (Sigma) was performed according
to the manufacturer's instructions.
Western blot analysis.
Cell lysates were prepared in buffer
containing 50 mM Tris-HCl, pH 7.4, 1% NP-40, 0.25% sodium
deoxycholate, 150 mM NaCl, 1 mM EGTA, 1 mM phenylmethylsulfonyl
fluoride, and 100 µl of protease inhibitor cocktail (Sigma). Cell
lysates were clarified by low-speed centrifugation to remove nuclei and
debris, and protein content was determined with Bio-Rad DC protein
assay kit (Hercules, Calif.) according to the manufacturer's
instructions. Samples (40 µg/lane) were electrophoresed on 10 to 12%
polyacrylamide gels and transferred to ProBlot membranes (Applied
Biosystems, Foster City, Calif.). Membranes were blocked overnight with
Tris-buffered saline containing 5% nonfat dry milk and 0.02% Tween
20, washed extensively, and incubated with rabbit polyclonal anti-human
TRAIL-R1 or R2 (1:500) (BioSource International, Camarillo, Calif.),
anti-human TRAIL (1:1,000) (Alexis Corporation) or anti-caspase 8 (1:100) (Santa Cruz Biotechnology, Santa Cruz, Calif.). After a
washing, the blots were incubated with horseradish
peroxidase-conjugated goat anti-rabbit antibody (Sigma), washed again,
and analyzed by enhanced chemiluminescence (ECL) using SuperSignal West
Dura as a substrate (Pierce, Rockford, Ill.).
Assay for viral RNA replication.
Viral RNA replication was
assayed by incorporation of [3H]uridine in the presence
of actinomycin D as previously described (23). Briefly,
after virus adsorption, 2 × 104 cells were incubated
in a 96-well plate with 100 µl of complete medium containing 5 µg
of actinomycin D per ml and 10 µCi of [3H]uridine (ICN;
15 to 25 Ci/mmol) per ml. At the indicated times, samples were
harvested with a PHD Cell Harvester (Cambridge Technologies, Watertown,
Mass.) and radioactivity was determined using a Beckman scintillation
counter (LS5000TD; Palo Alto, Calif.). The mean and standard deviation
of quadruplicate samples were calculated using Cricket Graph 1.3.
Immunoprecipitation of virus capsid proteins.
Immunoprecipitation of [35S]methionine-labeled virus
capsid proteins was as previously described (23). Briefly,
106 cells were incubated with 100 µCi of
L-[35S]methionine (ICN; 100 Ci/mmol) for
18 h postinfection (p.i.) and lysed in radioimmunoprecipitation
assay buffer. Lysates were clarified by centrifugation, and protein
content was determined as described above. After preclearing with
normal rabbit serum, BeAn proteins were immunoprecipitated with 5 µl
of polyclonal anti-BeAn rabbit antiserum and protein G-coupled
Sepharose beads (Sigma). Samples were solubilized in sample buffer and
electrophoresed on SDS-polyacrylamide gels.
Assay for caspase activity.
Caspase protease activity was
measured in cell lysates by release of aminomethylcoumarin from the
substrate peptide, acetyl-Asp-Glu-Val-Asp (DEVD), as previously
described (22).
RPA.
RNA was isolated from M1-D cells using TRIZOL Reagent
(Life Technologies, Grand Island, N.Y.) according to the
manufacturer's instructions. The RiboQuant Multi-Probe RNase
protection assay (RNA) (PharMingen) was used according to the
manufacturer's instructions to analyze RNA expression of the bcl-2
family (mAPO-1) and the TNF superfamily members (mAPO-2). Probes were
synthesized using [
-35S]UTP instead of
[
-32P]UTP. Densitometry scans were done on the STORM
860 PhosphorImager (Molecular Dynamics, Sunnyvale, Calif.) using
ImageQuant version 5.0 software. The numbers were derived as ratios of
the housekeeping gene, L32.
 |
RESULTS |
BeAn virus-induced apoptosis of IFN-
-activated M1-D cells.
While viral RNA replication (Fig. 1A),
expression of capsid proteins (Fig. 1B), and production of infectious
virus (22) were measurable in M1-D cells, there was no
evidence of viral RNA replication after activation with IFN-
as
measured by [3H]uridine incorporation (Fig. 1A) or of
viral protein expression as assayed by immunoprecipitation (Fig. 1B).
Mean fluorescence intensities of BeAn virus antigen staining by flow
cytometry in M1-D cells and activated M1-D cells were 145 and 18, respectively (Fig. 1C and D) (mean fluorescence intensities for
uninfected control cells were 4.6 and 9.7). Although flow cytometry
analysis indicated the presence of low levels of viral proteins in
activated M1-D cells, this probably represents residual virus and not
newly synthesized viral proteins. Plaque assays of lysates from
unactivated and activated M1-D cells showed that 2 to 2.5 PFU were
produced in each M1-D cell (four samples from two separately
differentiated populations done in duplicate) and showed consistent
titers of <0.1 PFU for each activated cell. Since activated M1-D cells
produce 10-fold higher levels of IFN-
/
than do M1-D cells
(22), the lack of BeAn replication and protein expression
in activated M1-D cells was not surprising (Fig. 1A, B, and D).
However, activated M1-D cells showed apoptotic changes after BeAn
infection including cell rounding, surface blebbing, and condensed
nuclei and loss of adherence (not shown). To confirm the mechanism of
virus-induced cell death of activated M1-D cells, caspase activity and
annexin V binding were assayed as early indicators of apoptosis
(32, 42, 47). Caspase activity increased fivefold in both
unactivated and activated infected M1-D cells by 8 h p.i. compared
to uninfected controls (Fig. 2A). The
kinetics of caspase induction were similar in the two cell populations
beginning
4 h p.i., peaking at 8 and 10 h and declining to
undetectable levels by 24 h (data not shown). The kinetics of annexin V
binding paralleled that of caspase activity, beginning 4 to 6 h
p.i. (Fig. 2B). Together these results indicate that both unactivated
and activated M1-D cells died by apoptosis after BeAn virus infection
(summarized in Table 1).

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 1.
Characteristics of BeAn virus infection in M1-D and
IFN- -activated M1-D cells. (A) BeAn RNA replication in unactivated
( ) or IFN- -activated ( ) M1-D cells. Cells were incubated in
100 µl of medium containing 1 µCi of [3H]uridine and
0.5 µg of actinomycin D and harvested at 2-h intervals. Data are
presented as means ± standard deviations of 6 samples. (B)
Immunoprecipitation of BeAn virus capsid proteins from lysates of
[35S]methionine-labeled BeAn-infected unactivated and
IFN- -activated M1-D cells. One million cell equivalents were lysed
in lysis buffer (see Materials and Methods), precleared with normal
rabbit serum, and immunoprecipitated with rabbit polyclonal anti-BeAn
antiserum. Immunoprecipitated proteins were resolved on a 12%
polyacrylamide gel; virus proteins are indicated. The experiment was
repeated twice with similar results. (C and D) Representative flow
cytometry histograms of permeabilized uninfected (solid line) and
infected (dashed line) unactivated (C) and IFN- -activated (D) M1-D
cells 6 h p.i. stained for BeAn virus antigen.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
Evidence for apoptosis in unactivated and
IFN- -activated M1-D cells. (A) Kinetics of caspase activity in
BeAn-infected unactivated ( ) and IFN- -activated ( ) M1-D cells
and uninfected control cells ( ). Lysates from 106 cells
were analyzed for the ability to cleave the DEVD-aminomethylcoumarin
substrate. Data are means of duplicate samples with microtiter plate
background values subtracted and are representative of two kinetic
experiments. Caspase activity was measured in three other preparations
of M1-D cells at 8.5 h p.i. with similar results. (B) Kinetics of
annexin V binding to BeAn-infected, unactivated ( ) and activated
( ) M1-D cells. Background values for uninfected cells were 8.2% ± 2.1% and 17.0% ± 6.5%, respectively. Values are representative of
two kinetic experiments. (C) MTT assay of cell viability with
increasing multiplicities of infection of BeAn virus in unactivated
( ) and activated ( ) M1-D cells. The results shown are
representative of four independent experiments. Quadruplicate samples
were averaged, and the results are expressed as percentages of
uninfected controls. The standard deviation for the OD readings was
less than 0.1 for all samples.
|
|
Up-regulation of TRAIL in BeAn-infected, IFN-
-activated M1-D
cells.
To determine whether the TNF family of proteins was altered
during IFN-
activation and/or BeAn virus infection, total RNA was
isolated at various times p.i. and analyzed by RPA. mRNA levels of
three TNF family members (FAF, TRADD, and RIP) (Fig.
3A) did not change under the conditions
tested, and that of FasL was not expressed. Densitometric analysis
relative to the housekeeping gene, L32, revealed that caspase 8 and
TNF-R p55 mRNA levels decreased with time after infection of
unactivated M1-D cells (Fig. 3B). IFN-
activation alone up-regulated
Fas and TNF-R p55 mRNAs, neither of which changed after infection (Fig.
3C). Caspase 8 mRNA expression increased almost twofold after infection
of activated cells, consistent with its role as an initiator caspase in
apoptosis (42). TRAIL mRNA was expressed in activated M1-D
cells beginning 4 h p.i. and increased 1.5-fold by 8 h (Fig.
3A and C). Neither IFN-
activation nor BeAn virus infection alone
was sufficient to initiate TRAIL mRNA transcription in unactivated M1-D
cells (Fig. 3A and C). Both signals were required to up-regulate TRAIL
mRNA, and its transcription correlated with the kinetics of apoptosis
(Fig. 2B).

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 3.
TRAIL mRNA expression in M1-D cells. (A) RPA of RNA
isolated from unactivated and IFN- -activated M1-D cells at 2-h
intervals after BeAn virus infection. Probes are shown in the far left
lane; protected RNA bands are labeled on the right and were identified
by size according to manufacturer's instructions. The time course was
repeated twice, and samples were subjected to RPA twice with similar
results. (B and C) Densitometry scans of RPA illustrated in panel A:
caspase 8 ( ), Fas ( ), TRAIL ( ), TNF-R p55 ( ), L32
housekeeping gene
( ), and
background
( ) in
unactivated (B) and IFN- -activated (C) M1-D cells.
|
|
Since the increase in caspase 8 mRNA in activated M1-D cells was
unexpected, immunoblotting of cell lysates harvested 4 to
8 h p.i.
with a polyclonal rabbit anti-caspase 8 antibody that
detects both the
proenzyme and the cleavage products was performed.
Procaspase 8 (50 to
55 kDa) was easily detected in activated M1-D
cells (Fig.
4B). The
cleavage products (~40 and 23 kDa) were detected
in all lysates, even
in the uninfected cells (Fig.
4A).
However,
only upon longer exposure (with higher background) was
procaspase
8 detected in unactivated cells (not shown). Although some
apoptotic
cells are always observed in M1-D cell cultures, the high
amount
of cleavage products in uninfected cells remains unexplained.

View larger version (74K):
[in this window]
[in a new window]
|
FIG. 4.
Caspase 8 expression in M1-D cells. Lysates from
unactivated (A) or IFN- -activated (B) M1-D cells at various times
after infection are shown. Mouse caspase 8 zymogen is ~50 to 55 kDa,
while cleaved products recognized by this antibody are ~40 and 23 kDa
as shown. The ECL was exposed for 2 min; the zymogen can be seen in
unactivated M1-D cells on longer exposure (20 min); however, background
levels are much higher. Cleavage products are seen in the uninfected
cell lysates from both cell populations (A and B). More of the
procaspase 8 is seen in the IFN- -activated M1-D cells than in the
unactivated cells.
|
|
Flow cytometry confirmed TRAIL protein expression 8 h p.i. in
activated M1-D cells decreasing by 24 h p.i. (Fig.
5A), and
the results were confirmed by
Western blotting (not shown). FasL
was not detectable by flow cytometry
even in the presence of metalloprotease
inhibitors (not shown).

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 5.
TRAIL protein expression in M1-D cells. (A) Flow
cytometry of cytoplasmic TRAIL expression in unactivated (light line)
and IFN- -activated M1-D cells (bold line) 4, 8, and 24 h p.i.,
respectively. (B) Western blot of unactivated and IFN- -activated
M1-D cell lysates prepared from samples harvested 4, 8, 12, and 24 h p.i. Polyclonal anti-human TRAIL-R1 (62 kDa) and R2 (62 kDa) (1:500)
followed by horseradish peroxidase-conjugated goat anti-rabbit IgG
antibody (1:50,000) were used for detection with SuperSignal West Dura
substrate by ECL. 3T3 cell lysate was used as a positive control as
suggested by the manufacturer.
|
|
Western blot analysis of the TRAIL receptors R1 (DR4) and R2 (DR5)
revealed a 62-kDa band in unactivated and activated M1-D
cells
regardless of infection (Fig.
5B). Staining uninfected mouse
3T3 cells
with rabbit polyclonal antibodies to human TRAIL-R1
and -R2 showed that
the antibodies cross-reacted with mouse receptors
for TRAIL (Fig.
5B).
A BLAST search for mouse TRAIL receptor sequences
revealed a single
expressed sequence tag clone with homology to
human TRAIL-R2 (DR5) but
no sequence homology to TRAIL-R1 (Mouse
EST Project, Washington
University, St. Louis, Mo.). Whether the
two proteins identified as
mouse TRAIL receptors are actually
two distinct proteins or
cross-reactive species remains to be
determined. Nonetheless, M1-D
cells expressed TRAIL receptor proteins
prior to activation and
infection.
Effects of sTRAIL, FasL, and TNF-
on M1-D cell viability.
To determine whether TRAIL receptors were functional in unactivated and
activated M1-D cells, soluble TRAIL (sTRAIL) was added to cell cultures
and cell viability was analyzed by the MTT assay. Cell death in
activated M1-D cells was induced in a dose-dependent manner and
averaged 28% (72% viability) at 1 µg of soluble TRAIL per ml (Fig.
6A). Interestingly, unactivated M1-D
cells proliferated in the presence of TRAIL, averaging 125% above
control values. These results were consistent in two separate
experiments using two independently derived M1-D cell populations. The
low biological activity of TRAIL in these experiments probably reflects
the absence of artificial trimerization, which is required for full
biological activity of TRAIL, TNF-
, and FasL (5, 45,
46). Nevertheless, TRAIL at higher concentrations significantly
decreased cell viability over control cultures in a dose-dependent
fashion (Fig. 6A).

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 6.
Ability of soluble death ligands to induce apoptosis in
unactivated and IFN- -activated M1-D cells. (A) Percent viability,
measured by the MTT assay, of unactivated ( ) and IFN- -activated
( ) M1-D cells treated with increasing amounts of soluble TRAIL.
Formazan crystal formation was measured 20 to 22 h after treatment
with soluble TRAIL. Quadruplicate samples were averaged, and the
results are expressed as percentages of values for uninfected controls
(P < 0.02). Results are representative of three
independent experiments. (B) Percent viability of unactivated (black
columns) and IFN- -activated (gray columns) M1-D cells with soluble
TRAIL, FasL, and TNF- measured by the MTT assay. Data are presented
as means ± standard deviations (SD) of four independent
measurements with two different M1-D cell populations. Concentrations
are shown. (C) TNF- in supernatants of M1-D cells measured by
immunoassay. Supernatants collected at time zero were harvested 24 h after the initial cultures were plated. Symbols: , uninfected
M1-D; , BeAn-infected M1-D; , IFN- -activated, uninfected M1-D;
, IFN- -activated, BeAn-infected M1-D. Means of quadruplicate
samples and SD are shown.
|
|
Since both Fas and TNF-R p55 RNA were upregulated with activation,
their respective ligands, soluble FasL and TNF-

, were
examined for
their effects. When soluble FasL and TNF-

were added
to activated
M1-D cell cultures, viability levels similar to those
using sTRAIL were
observed, although 10-fold more FasL than TRAIL
or TNF-

was required
to induce equivalent levels of cell death
(Fig.
6B). In unactivated
M1-D cells, TNF-

killed to levels comparable
to that for activated
M1-D cells, whereas both TRAIL and FasL
stimulated cells to
proliferate. The stimulatory activity for
Fas-FasL interaction has been
reported in T cells and human monocytes
(
28,
31).
Another possible mechanism of apoptosis induction is signaling through
TNF-R, because TNF-R p55 mRNA was up-regulated after
infection (Fig.
3). Since soluble TNF-

was as effective as TRAIL
and FasL in killing
activated M1-D cells and activated M

s are
known to secrete TNF-

(
1), TNF-

levels in the supernatant
of cell cultures
were measured by an immunoassay. Supernatants
collected 24 h after
IFN-

treatment showed a 1.5-fold increase
in TNF-

concentration
compared to untreated cells (Fig.
6C).
Activated M1-D cell supernatants
collected 24 h p.i. secreted
8.5-fold more TNF-

compared to
uninfected, activated cells. TNF-
levels in activated M1-D cells
rose quickly and plateaued at 8
h p.i. Uninfected,
IFN-

-activated cells showed little change
after the initial 24-h
accumulation of TNF-

(shown on the graph
as 0 h). TNF-

levels in
supernatants from unactivated, BeAn-infected
M1-D cells increased
2.1-fold 24 h p.i. compared to uninfected
cells.
To assess the relative contributions of TRAIL, FasL, and TNF-

in
BeAn virus-induced apoptosis, antibodies to the three molecules
were
added to cell cultures at concentrations varying from 10
to 0.001 µg/ml. (Three sources of anti-TRAIL antibodies were used.)
Incubation
with anti-TRAIL, anti-TNF-

, or anti-FasL did not inhibit
apoptosis
of infected, unactivated M1-D cells, but potentiated
cell death of
infected, IFN-

-activated cells (not shown). The
antibodies were not
toxic when tested on uninfected cells. Although
inhibition of apoptosis
with ligand-specific antibodies has been
reported in the literature
(
9,
10,
25,
26,
48), we
were unable to duplicate the
response with the above-mentioned
antibodies. The significance of these
data is not clear in light
of the ability of soluble ligands to induce
apoptosis in activated
M1-D cells. Perhaps the Fc receptors on these
M

-like cells are
providing another cell death-inducing
signal.
Another approach to assess the relative contributions of TNF-

and
TRAIL is to use the corresponding receptor molecules to
neutralize
ligand function. sTNF-RII and rhTRAIL-R2:Fc were added
to M1-D cultures
4 h p.i., and cell viability was measured by
the MTT assay (Fig.
7). Infected, unactivated M1-D cells were
not protected by these molecules; however, both soluble receptors
protected activated M1-D cells from virus-induced cell death by
36 to
52% in a dose-dependent fashion. Addition of inhibitors
1 h p.i.
had no effect.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 7.
Inhibition of BeAn virus-induced cell death by TNF-RII
and TRAIL-R2. BeAn-infected unactivated (A) or IFN- -activated (B)
M1-D cells were incubated with increasing concentrations of either
sTNF-RII (open bars) or rhTRAIL-R2:Fc (gray bars), and cell viability
was assayed by MTT 20 h p.i. Results are shown as mean
OD560 and standard deviations of quadruplicate samples. The
inhibitors protected IFN- -activated M1-D cells, whereas no
protection occurred in the unactivated M1-D cells. This experiment was
repeated with similar trends.
|
|
 |
DISCUSSION |
Apoptosis can be triggered by a number of stimuli, including viral
infections (36) and cell stress (19)
(intrinsic pathway), and cell surface signaling through the death
receptors and their ligands (TNF-
, FasL, and TRAIL) (5)
(extrinsic pathway). Our data indicate that both pathways are utilized
in BeAn-infected M
s depending on their activation state. Although
poliovirus proteins 3C (7) and 2A (15) induce
apoptosis directly, the mechanism of apoptosis induction by
picornavirus infections has not been clearly defined. Using a yeast
two-hybrid system, Henke et al. (20) demonstrated binding
of coxsackievirus B3 VP2 to the proapoptotic siva protein; however,
TMEV VP2 showed no such binding. Agol et al. (2, 3)
described two competing death programs initiated with poliovirus
infection: one dependent on caspases to initiate the apoptosis program
and the other independent of caspases and resulting in cell death
without the hallmarks of apoptosis (canonical cytopathic effect).
Our data show that BeAn virus induces caspase 3-dependent apoptosis in
both unactivated and activated M1-D cells. However, BeAn-induced
apoptosis in activated M1-D cells is not accompanied by virus
replication, whereas apoptosis in unactivated cells requires virus
replication. In addition, caspase 8 (an initiator caspase) mRNA
expression increases with infection of activated cells, whereas it
appears to be degraded in unactivated cells (Fig. 3A and C). The
results of Western blotting for caspase 8 protein indicate that the
protein is cleaved prior to infection in both unactivated and activated
M1-D cells. Caspase 8, as well as the other 13 caspases, resides in the
cytoplasm as inactive zymogens, which are cleaved upon activation to
initiate the apoptosis program (19). Recent evidence has
shown that caspase 8 is cleaved in activated T cells and may be
involved in proliferation (4, 27). Los et al. (30) have postulated that caspase 8 may be involved in
cell-cycle progression, another checkpoint assuring that only healthy
cells progress through the cell cycle. Our data suggest that the
caspase 8 proenzyme is already cleaved in M1-D cells. Thus, since M1-D cells have been differentiated in vitro, caspase 8 in these cells may
be activated and function in the control of the cell cycle. A more
detailed analysis of the caspase family members in M1-D as well as the
precursor M1 cells will be required to resolve this issue. Nonetheless,
it appears that activated M1-D cells have more of the unprocessed
protein present than the unactivated cells, which supports the findings
of the RPA.
Since IFN-
activation sensitizes death receptors to signaling from
their ligands (Fig. 4B), a phenomenon termed activation-induced cell
death (24), and BeAn virus infection stimulates production of the ligands, a logical explanation for these data is that M1-D cells
generate signals for their own demise. The only source of death-inducing ligands in this system is the activated M1-D cells themselves. Two candidate ligands for apoptosis induction in
BeAn-infected, activated M1-D cells are TRAIL and TNF-
. After
infection, TRAIL mRNA and protein expression are up-regulated and high
levels of TNF-
are found in the supernatant (Fig. 3 and 6C,
respectively). Thus, apoptosis through either ligand is possible.
Inhibition of cell death by both sTNF-RII and rhTRAIL-R2 indicates that
both molecules are used in this system. These data for cell death
receptor and ligand expression are summarized in Table
2.
Two cell death-signaling pathways have been described: an intrinsic
pathway due to cellular stress which is dependent on mitochondrial release of cytochrome c and caspase 9 activation and
controlled through the Bcl-2 family (17) and an extrinsic
pathway which is dependent on ligand binding to death receptors,
recruitment of FADD/Mort adaptor molecules, and caspase 8 activation
(38). A recent report by Walczak et al. (44)
describes experiments in which overexpression of Bcl-2 had no effect on
TRAIL-induced apoptosis and expression of caspase 8 was necessary and
sufficient for TRAIL-induced apoptosis. Sprick et al. (41)
also reported that FADD/Mort1 and caspase 8 are essential for
TRAIL-induced apoptosis. Additional evidence that the death receptors
and their ligands are involved in BeAn virus-induced apoptosis in
activated M1-D cells is that Bcl-2 overexpression had no effect either
on caspase 3 activation or on cell viability (unpublished). RPA
analysis for seven bcl-2 family members (bcl-W, bfl1, bcl-X, bak, bax, bcl-2, and bad) showed no change in expression with time after infection (unpublished). Therefore, in activated M1-D cells the intrinsic mitochondria-dependent apoptosis mechanism is not used and
apoptosis occurs through the extrinsic pathway. Confirmation of this
hypothesis awaits detailed analysis of the caspase cascade in these cells.
Recently, various investigators have reported TRAIL up-regulation after
infection with several viruses including human cytomegalovirus in
fibroblasts (40), measles virus in human monocyte-derived dendritic cells, monocytes, and CD3-activated T cells
(43), and reovirus infection in fibroblasts
(10). To our knowledge, this is the first report to show
that a picornavirus up-regulates TRAIL in an activated M
-like cell
line and broadens the range of viruses affecting the TRAIL apoptosis pathway.
It was recently reported that human monocyte-derived M
s expressed
TRAIL after IFN-
and IFN-
treatment but resisted TRAIL-mediated apoptosis (18). IFN-
and IFN-
by themselves did not
up-regulate TRAIL expression in our system, but did sensitize M1-D
cells to signaling from their death receptors. Additional signals,
provided by BeAn virus infection, were required to upregulate TRAIL.
Whether this discrepancy is due to species differences, use of primary versus tumor cells, or the different methods of M
differentiation induction is unclear.
IFNs (type 1 and 2) induce double-stranded RNA-dependent protein kinase
(PKR), which mediates apoptosis (16). To assess the role
of PKR in our system, we obtained undifferentiated M1 cells expressing
a PKR mutation (p68
6 [6, 35]); however, we were
unable to differentiate these cells in vitro (unpublished data).
Infection of mouse peritoneal M
s and CNS microglia from normal mice
and mice with the PKR mutation could provide further information on
apoptosis-signaling mechanisms in M
s at different stages of
activation. Until recently, we have been unable to infect peritoneal
M
s with BeAn virus; however, we are now examining the role of TRAIL,
TNF-
, and Fas in apoptosis induction by infection of these cells.
Continuous up-regulation of IFN-
and TNF-
in the CNS has been
reported during the course of TMEV-induced demyelinating disease
(8), which may play a role in the immunopathology of the
disease. Whether TRAIL also contributes to the immunopathology induced
by TMEV is unknown but now merits further study.
 |
ACKNOWLEDGMENTS |
We thank J. Pan for soluble TRAIL, A. Kimchi for the M1 cells
expressing the PKR mutation, H. Yagita for the N2B2 antibody, and Mark
Trottier for critical review of the manuscript.
This work was supported by NIH grant NS23349 and the Leiper Foundation.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: ENH Research
Institute, 2650 Ridge Ave., Evanston, IL 60201. Phone: (847) 570-2378. Fax: (847) 570-1934. E-mail: mlj461{at}northwestern.edu.
 |
REFERENCES |
| 1.
|
Adams, D. O., and T. A. Hamilton.
1992.
Molecular basis of macrophage activation diversity and its origins, p. 77-114.
In
C. E. Lewis, and J. O. D. McGee (ed.), The natural immune system: the macrophage. IRL Press, New York, N.Y.
|
| 2.
|
Agol, V. I.,
G. A. Belov,
K. Bienz,
D. Egger,
M. S. Kolesnikova,
N. T. Raikhlin,
L. I. Romanova,
E. A. Smirnova, and E. A. Tolskaya.
1998.
Two types of death of poliovirus-infected cells: caspase involvement in the apoptosis but not cytopathic effect.
Virology
252:343-353[CrossRef][Medline].
|
| 3.
|
Agol, V. I.,
G. A. Belov,
K. Bienz,
D. Egger,
M. S. Kolesnikova,
L. I. Romanova,
L. V. Sladkova, and E. A. Tolskaya.
2000.
Competing death programs in poliovirus-infected cells: commitment switch in the middle of the infectious cycle.
J. Virol.
74:5534-5541[Abstract/Free Full Text].
|
| 4.
|
Alam, A.,
L. Y. Cohen,
S. Aouad, and R.-P. Sékaly.
1999.
Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells.
J. Exp. Med.
190:1879-1890[Abstract/Free Full Text].
|
| 5.
|
Ashkenazi, A., and V. M. Dixit.
1998.
Death receptors: signaling and modulation.
Science
281:1305-1308[Abstract/Free Full Text].
|
| 6.
|
Barber, G. N.,
R. Jagus,
E. F. Meurs,
A. G. Hovanessian, and M. G. Katze.
1995.
Molecular mechanisms responsible for malignant transformation by regulatory and catalytic domain variants of the interferon-induced enzyme RNA-dependent protein kinase.
J. Biol. Chem.
270:17423-17428[Abstract/Free Full Text].
|
| 7.
|
Barco, A.,
E. Feduchi, and L. Carrasco.
2000.
Poliovirus protease 3C(pro) kills cells by apoptosis.
Virology
266:352-360[CrossRef][Medline].
|
| 8.
|
Begolka, W. S.,
C. L. Vanderlugt,
S. M. Rahbe, and S. D. Miller.
1998.
Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
J. Immunol.
161:4437-4446[Abstract/Free Full Text].
|
| 9.
|
Bermudez, L. E.,
A. Parker, and M. Petrofsky.
1999.
Apoptosis of Mycobacterium avium-infected macrophages is mediated by both tumour necrosis factor (TNF) and Fas, and involves the activation of caspases.
Clin. Exp. Immunol.
116:94-99[CrossRef][Medline].
|
| 10.
|
Clarke, P.,
S. M. Meintzer,
S. Gibson,
C. Widmann,
T. P. Garrington,
G. L. Johnson, and K. L. Tyler.
2000.
Reovirus-induced apoptosis is mediated by TRAIL.
J. Virol.
74:8135-8139[Abstract/Free Full Text].
|
| 11.
|
Clatch, R. J.,
R. W. Melvold,
S. D. Miller, and H. L. Lipton.
1985.
Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TEMV-specific delayed-type hypersensitivity.
J. Immunol.
135:1408-1414[Abstract].
|
| 12.
|
Clatch, R. J.,
S. D. Miller,
R. Metzner,
M. C. Dal Canto, and H. L. Lipton.
1990.
Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV).
Virology
176:244-254[CrossRef][Medline].
|
| 13.
|
Gerety, S. J.,
W. J. Karpus,
A. R. Cubbon,
R. G. Goswami,
M. K. Rundell,
J. D. Peterson, and S. D. Miller.
1994.
Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice.
J. Immunol.
152:908-918[Abstract].
|
| 14.
|
Gerety, S. J.,
M. K. Rundell,
M. C. Dal Canto, and S. D. Miller.
1994.
Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope.
J. Immunol.
152:919-929[Abstract].
|
| 15.
|
Goldstaub, D.,
A. Gradi,
Z. Bercovitch,
Z. Grosmann,
Y. Nophar,
S. Luria,
N. Sonnenberg, and C. Kahana.
2000.
Poliovirus 2A protease induces apoptotic cell death.
Mol. Cell. Biol.
20:1271-1277[Abstract/Free Full Text].
|
| 16.
|
Goodbourn, S.,
L. Didcock, and R. E. Randall.
2000.
Interferons: cell signalling, immune modulation, antiviral responses and virus countermeasures.
J. Gen. Virol.
81:2341-2364[Free Full Text].
|
| 17.
|
Green, D. R., and J. C. Reed.
1998.
Mitochondria and apoptosis.
Science
281:1309-1312[Abstract/Free Full Text].
|
| 18.
|
Griffith, T. S.,
S. R. Wiley,
M. Z. Kubin,
L. M. Sedger,
C. R. Maliszewski, and N. A. Fanger.
1999.
Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.
J. Exp. Med.
189:1343-1354[Abstract/Free Full Text].
|
| 19.
|
Grutter, M. G.
2000.
Caspases: key players in programmed cell death.
Curr. Opin. Struct. Biol.
10:649-655[CrossRef][Medline].
|
| 20.
|
Henke, A.,
H. Launhardt,
K. Klement,
A. Stelzner,
R. Zell, and T. Munder.
2000.
Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva.
J. Virol.
74:4284-4290[Abstract/Free Full Text].
|
| 21.
|
Jelachich, M. L.,
P. Bandyopadhyay,
K. Blum, and H. L. Lipton.
1995.
Theiler's virus growth in murine macrophage cell lines depends on the state of differentiation.
Virology
209:437-444[CrossRef][Medline].
|
| 22.
|
Jelachich, M. L.,
C. Bramlage, and H. L. Lipton.
1999.
Differentiation of M1 myeloid precursor cells into macrophages results in binding and infection by Theiler's murine encephalomyelitis virus and apoptosis.
J. Virol.
73:3227-3235[Abstract/Free Full Text].
|
| 23.
|
Jelachich, M. L., and H. L. Lipton.
1996.
Theiler's murine encephalomyelitis virus kills restrictive but not permissive cells by apoptosis.
J. Virol.
70:6856-6861[Abstract/Free Full Text].
|
| 24.
|
Kabelitz, D.,
T. Pohl, and K. Pechhold.
1993.
Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes.
Immunol. Today
14:338-339[CrossRef][Medline].
|
| 25.
|
Kaplan, M. J.,
D. Ray,
R. R. Mo,
R. L. Yung, and B. C. Richardson.
2000.
TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages.
J. Immunol.
164:2897-2904[Abstract/Free Full Text].
|
| 26.
|
Kayagaki, N.,
N. Yamaguchi,
M. Nakayama,
K. Takeda,
H. Akiba,
H. Tsutsui,
H. Okamura,
K. Nakanishi,
K. Okumura, and H. Yagita.
1999.
Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
J. Immunol.
163:1906-1913[Abstract/Free Full Text].
|
| 27.
|
Kennedy, N. J.,
T. Kataoka,
J. Tschopp, and R. C. Budd.
1999.
Caspase activation is required for T cell proliferation.
J. Exp. Med.
190:1891-1895[Abstract/Free Full Text].
|
| 28.
|
Kiener, P. A.,
P. M. Davis,
B. M. Rankin,
S. J. Klebanoff,
J. A. Ledbetter,
G. C. Starling, and W. C. Liles.
1997.
Human monocytic cells contain high levels of intracellular Fas ligand.
J. Immunol.
159:1594-1598[Abstract].
|
| 29.
|
Lipton, H. L.,
G. Twaddle, and M. L. Jelachich.
1995.
The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease.
J. Virol.
69:2525-2533[Abstract].
|
| 30.
|
Los, M.,
C. Stroh,
R. U. Janicke,
I. H. Engels, and K. Schulze-Osthoff.
2001.
Caspases: more than just killers?
Trends Immunol.
22:31-34[CrossRef][Medline].
|
| 31.
|
Lynch, D. H.,
F. Ramsdell, and M. R. Alderson.
1995.
Fas and FasL in the homeostatic regulation of immune responses.
Immunol. Today
16:569-574[CrossRef][Medline].
|
| 32.
|
Martin, S. J.,
C. P. M. Reutelingsperger,
A. J. McGahon,
J. A. Rader,
R. C. A. A. van Schie,
D. M. LaFace, and D. R. Green.
1995.
Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl.
J. Exp. Med.
182:1545-1556[Abstract/Free Full Text].
|
| 33.
|
Miller, S. D.,
R. J. Clatch,
D. C. Pevear,
J. L. Trotter, and H. L. Lipton.
1987.
Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins.
J. Immunol.
138:3776-3784[Abstract].
|
| 34.
|
Miller, S. D.,
S. J. Gerety,
M. K. Kennedy,
J. D. Peterson,
J. L. Trotter,
V. K. Touhy,
C. Waltenbaugh,
M. C. Dal Canto, and H. L. Lipton.
1989.
Class-II restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination.
J. Neuroimmunol.
26:9-23.
|
| 35.
|
Raveh, T.,
A. G. Hovanessian,
E. F. Meurs,
N. Sonenberg, and A. Kimchi.
1996.
Double-stranded RNA-dependent protein kinase mediates c-Myc suppression induced by type I interferons.
J. Biol. Chem.
271:25479-25484[Abstract/Free Full Text].
|
| 36.
|
Razvi, E. S., and R. M. Welch.
1995.
Apoptosis in viral infections.
Adv. Virus Res.
45:1-60[Medline].
|
| 37.
|
Rossi, C. P.,
M. Delcroix,
I. Huitinga,
A. McAllister,
N. van Rooijen,
E. Claassen, and M. Brahic.
1997.
Role of macrophages during Theiler's virus infection.
J. Virol.
71:3336-3340[Abstract].
|
| 38.
|
Roy, S., and D. W. Nicholson.
2000.
Cross-talk in cell death signaling.
J. Exp. Med.
192:21-26.
|
| 39.
|
Rozhon, E. J.,
J. D. Kratochvil, and H. L. Lipton.
1983.
Analysis of genetic variation in Theiler's virus during persistent infection in the mouse central nervous system.
Virology
128:16-32[CrossRef][Medline].
|
| 40.
|
Sedger, L. M.,
D. M. Shows,
R. A. Blanton,
J. J. Peschon,
R. G. Cosman, and S. R. Wiley.
1999.
IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression.
J. Immunol.
163:920-926[Abstract/Free Full Text].
|
| 41.
|
Sprick, M. R.,
M. A. Weigand,
E. Rieser,
C. T. Rauch,
P. Juo,
J. Blenis,
P. H. Krammer, and H. Walczak.
2000.
FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2.
Immunity
12:599-609[CrossRef][Medline].
|
| 42.
|
Thornberry, N. A., and Y. A. Lazebnik.
1998.
Caspases: enemies within.
Science
281:1312-1316[Abstract/Free Full Text].
|
| 43.
|
Vidalain, P. O.,
O. Azocar,
B. Lamouille,
A. Astier,
C. Rabourdin-Combe, and C. Servet-Delprat.
2000.
Measles virus induces functional TRAIL production by human dendritic cells.
J. Virol.
74:556-559[Abstract/Free Full Text].
|
| 44.
|
Walczak, H.,
A. Bouchon,
H. Stahl, and P. H. Krammer.
2000.
Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2-or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
Cancer Res.
60:3051-3057[Abstract/Free Full Text].
|
| 45.
|
Walczak, H.,
R. E. Miller,
K. Ariail,
B. Gliniak,
T. S. Griffith,
M. Kubin,
W. Chin,
J. Jones,
A. Woodward,
T. Le,
C. Smith,
P. Smolak,
R. G. Goodwin,
C. T. Rauch,
J. C. L. Schuh, and D. H. Lynch.
1999.
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Nat. Med.
5:157-163[CrossRef][Medline].
|
| 46.
|
Wiley, S. R.,
K. Schooley,
P. J. Smolak,
W. S. Din,
C.-P. Huang,
J. K. Nicholl,
G. R. Sutherland,
T. D. Smith,
C. Rauch,
C. A. Smith, and R. G. Goodwin.
1995.
Identification and characterization of a new member of the TNF family that induces apoptosis.
Immunity
3:673-682[CrossRef][Medline].
|
| 47.
|
Zhang, G.,
V. Gurtu,
S. R. Kain, and G. Yan.
1997.
Early detection of apoptosis using a fluorescent conjugate of annexin V.
Biotechniques
23:525-531[Medline].
|
| 48.
|
Zhao, S.,
Z. Asgary,
Y. Wang,
R. Goodwin,
M. Andreeff, and A. Younes.
1999.
Functional expression of TRAIL by lymphoid and myeloid tumour cells.
Br. J. Haematol.
106:827-832[CrossRef][Medline].
|
Journal of Virology, July 2001, p. 5930-5938, Vol. 75, No. 13
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.13.5930-5938.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Romanova, L. I., Lidsky, P. V., Kolesnikova, M. S., Fominykh, K. V., Gmyl, A. P., Sheval, E. V., Hato, S. V., van Kuppeveld, F. J. M., Agol, V. I.
(2009). Antiapoptotic Activity of the Cardiovirus Leader Protein, a Viral "Security" Protein. J. Virol.
83: 7273-7284
[Abstract]
[Full Text]
-
Fan, J., Son, K.-N., Arslan, S. Y., Liang, Z., Lipton, H. L.
(2009). Theiler's Murine Encephalomyelitis Virus Leader Protein Is the Only Nonstructural Protein Tested That Induces Apoptosis When Transfected into Mammalian Cells. J. Virol.
83: 6546-6553
[Abstract]
[Full Text]
-
Son, K.-N., Becker, R. P., Kallio, P., Lipton, H. L.
(2008). Theiler's Virus-Induced Intrinsic Apoptosis in M1-D Macrophages Is Bax Mediated and Restricts Virus Infectivity: a Mechanism for Persistence of a Cytolytic Virus. J. Virol.
82: 4502-4510
[Abstract]
[Full Text]
-
Lidsky, P. V., Hato, S., Bardina, M. V., Aminev, A. G., Palmenberg, A. C., Sheval, E. V., Polyakov, V. Y., van Kuppeveld, F. J. M., Agol, V. I.
(2006). Nucleocytoplasmic Traffic Disorder Induced by Cardioviruses. J. Virol.
80: 2705-2717
[Abstract]
[Full Text]
-
Belov, G. A., Lidsky, P. V., Mikitas, O. V., Egger, D., Lukyanov, K. A., Bienz, K., Agol, V. I.
(2004). Bidirectional Increase in Permeability of Nuclear Envelope upon Poliovirus Infection and Accompanying Alterations of Nuclear Pores. J. Virol.
78: 10166-10177
[Abstract]
[Full Text]
-
Kumar, A. S. M., Reddi, H. V., Kung, A. Y., Dal Canto, M., Lipton, H. L.
(2004). Virus Persistence in an Animal Model of Multiple Sclerosis Requires Virion Attachment to Sialic Acid Coreceptors. J. Virol.
78: 8860-8867
[Abstract]
[Full Text]
-
Kassis, R., Larrous, F., Estaquier, J., Bourhy, H.
(2004). Lyssavirus Matrix Protein Induces Apoptosis by a TRAIL-Dependent Mechanism Involving Caspase-8 Activation. J. Virol.
78: 6543-6555
[Abstract]
[Full Text]
-
Oleszak, E. L., Chang, J. R., Friedman, H., Katsetos, C. D., Platsoucas, C. D.
(2004). Theiler's Virus Infection: a Model for Multiple Sclerosis. Clin. Microbiol. Rev.
17: 174-207
[Abstract]
[Full Text]
-
Schlitt, B. P., Felrice, M., Jelachich, M. L., Lipton, H. L.
(2003). Apoptotic Cells, Including Macrophages, Are Prominent in Theiler's Virus-Induced Inflammatory, Demyelinating Lesions. J. Virol.
77: 4383-4388
[Abstract]
[Full Text]
-
Zhang, H.-G., Xie, J., Xu, L., Yang, P., Xu, X., Sun, S., Wang, Y., Curiel, D. T., Hsu, H.-C., Mountz, J. D.
(2002). Hepatic DR5 Induces Apoptosis and Limits Adenovirus Gene Therapy Product Expression in the Liver. J. Virol.
76: 5692-5700
[Abstract]
[Full Text]